202 related articles for article (PubMed ID: 19592488)
1. NDRG4 is required for cell cycle progression and survival in glioblastoma cells.
Schilling SH; Hjelmeland AB; Radiloff DR; Liu IM; Wakeman TP; Fielhauer JR; Foster EH; Lathia JD; Rich JN; Wang XF; Datto MB
J Biol Chem; 2009 Sep; 284(37):25160-9. PubMed ID: 19592488
[TBL] [Abstract][Full Text] [Related]
2. NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.
Kolodziej MA; Weischer C; Reinges MH; Uhl E; Weigand MA; Schwarm FP; Schänzer A; Acker T; Quint K; Uhle F; Stein M
Anticancer Res; 2016 Mar; 36(3):887-97. PubMed ID: 26976975
[TBL] [Abstract][Full Text] [Related]
3. NDRG4 is downregulated in glioblastoma and inhibits cell proliferation.
Ding W; Zhang J; Yoon JG; Shi D; Foltz G; Lin B
OMICS; 2012 May; 16(5):263-7. PubMed ID: 22489821
[TBL] [Abstract][Full Text] [Related]
4. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
[TBL] [Abstract][Full Text] [Related]
5. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart.
Zhou RH; Kokame K; Tsukamoto Y; Yutani C; Kato H; Miyata T
Genomics; 2001 Apr; 73(1):86-97. PubMed ID: 11352569
[TBL] [Abstract][Full Text] [Related]
7. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family.
Qu X; Zhai Y; Wei H; Zhang C; Xing G; Yu Y; He F
Mol Cell Biochem; 2002 Jan; 229(1-2):35-44. PubMed ID: 11936845
[TBL] [Abstract][Full Text] [Related]
8. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
[TBL] [Abstract][Full Text] [Related]
9. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function.
Shi HH; Liu HE; Luo XJ
BMB Rep; 2020 Dec; 53(12):658-663. PubMed ID: 33298240
[TBL] [Abstract][Full Text] [Related]
11. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.
Kotipatruni RP; Ferraro DJ; Ren X; Vanderwaal RP; Thotala DK; Hallahan DE; Jaboin JJ
Integr Biol (Camb); 2012 Oct; 4(10):1185-97. PubMed ID: 22869042
[TBL] [Abstract][Full Text] [Related]
12. Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.
Schonkeren SL; Massen M; van der Horst R; Koch A; Vaes N; Melotte V
Neurogenetics; 2019 Oct; 20(4):173-186. PubMed ID: 31485792
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
Li S; Yang B; Li G; He S; Li Y
Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
[TBL] [Abstract][Full Text] [Related]
16. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
17. GSK3beta regulates differentiation and growth arrest in glioblastoma.
Korur S; Huber RM; Sivasankaran B; Petrich M; Morin P; Hemmings BA; Merlo A; Lino MM
PLoS One; 2009 Oct; 4(10):e7443. PubMed ID: 19823589
[TBL] [Abstract][Full Text] [Related]
18. BMI1 sustains human glioblastoma multiforme stem cell renewal.
Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
[TBL] [Abstract][Full Text] [Related]
19. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
20. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
